Home > Riviste > Minerva Endocrinology > Fascicoli precedenti > Minerva Endocrinologica 2020 September;45(3) > Minerva Endocrinologica 2020 September;45(3):273-5

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

LETTERS TO THE EDITOR   

Minerva Endocrinologica 2020 September;45(3):273-5

DOI: 10.23736/S0391-1977.20.03122-3

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway

Shufeng CHENG 1, Liang LI 2, Chunquan SONG 3, Huijing JIN 4, Shouguo MA 5, Ping KANG 6

1 Department of Nephrology, People’s Hospital of Zhangqiu Area, Jinan, China; 2 Department of Pharmacy, Yidu Central Hospital, Weifang, China; 3 Department of Pharmacy, Qingdao Central Hospital, Qingdao, China; 4 Ward Department, People’s Hospital of Zhangqiu Area, Jinan, China; 5 Department of Burn and Plastic Surgery, People’s Hospital of Zhangqiu Area, Jinan, China; 6 Department of Rehabilitation, People’s Hospital of Zhangqiu Area, Jinan, China



inizio pagina